US Stock MarketDetailed Quotes
UBX Unity Biotechnology
- 1.6000
- -0.0100-0.62%
Close May 6 16:00 ET
- 1.6100
- +0.0100+0.63%
Post 18:41 ET
26.86MMarket Cap-592P/E (TTM)
1.6500High1.5900Low39.62KVolume1.6200Open1.6100Pre Close63.94KTurnover0.27%Turnover RatioLossP/E (Static)16.79MShares3.820052wk High0.95P/B23.21MFloat Cap1.460052wk Low--Dividend TTM14.51MShs Float245.6000Historical High--Div YieldTTM3.73%Amplitude1.4600Historical Low1.6130Avg Price1Lot Size
About Unity Biotechnology Company
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.
Company Profile
SymbolUBX
Company NameUnity Biotechnology
Listing DateMay 3, 2018
Issue Price17.00
Founded2009
CEODr. Anirvan Ghosh, PhD
MarketNASDAQ
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address285 East Grand Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-416-1192
Company Executives
- Name
- Position
- Salary
- Dr. Anirvan Ghosh, PhD
- Director and Chief Executive Officer
- 2.03M
- Lynne Sullivan
- Chief Financial Officer, Principal Accounting Officer and Head of Corporate Development
- 1.08M
- Keith R. Leonard, Jr
- Chairman of the Board
- 80.75K
- Dr. Nathaniel E. David, PhD
- Director
- 50.75K
- Camille D. Samuels
- Independent Director
- 61.25K
- Michael P. Samar
- Independent Director
- 60.93K
- Dr. Gilmore O’Neill, M.B.
- Independent Director
- 55.75K
- Dr. Margo R. Roberts, PhD.
- Independent Director
- 54.75K
- Paul L. Berns
- Lead Independent Director
- 88.25K
- Alexander Hieu Nguyen, J.D.
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg